Lipocine (LPCN) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of$0.56. This compares to a loss of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.36$0.41 per share when it actually produced a loss of $0.41, delivering no surprise.Over the last four quarters, the company h ...